Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Clinical Trials in Immune Tolerance

    Clinical Trials in Immune Tolerance supports scientists conducting clinical trials, tolerance assays, and mechanistic studies to induce and understand immune tolerance across four disease areas.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Immune Tolerance Network

    Due Dates: Rolling (Concept Proposals) | January 15, 2027 (Liver Transplant RFP: Letter of Interest review begins)

    Funding Amounts: Not specified

    Summary: Supports clinical trials, tolerance assays, and mechanistic studies to induce and understand immune tolerance across four disease areas.

    Key Information: Scientists from academia, industry, and government may apply; non-human and preclinical studies are not accepted.


    Description

    The Immune Tolerance Network (ITN) accepts proposals for novel clinical trials built around testable hypotheses for inducing immune tolerance. Its scope spans allergy and asthma, autoimmune disease, transplantation, and type 1 diabetes. ITN is an international clinical research consortium supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, with a collaborative approach to developing and evaluating tolerance therapies.

    Alongside trials, ITN supports novel tolerance assays and mechanistic studies that establish surrogate biomarkers or investigate mechanisms of clinical tolerance. Proposals may also use ITN tolerance-assay resources within existing or planned trials funded elsewhere. Targeted requests seek mechanistically focused environmental allergen immunotherapy trials and tolerance trials in adult liver transplantation.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.